Long-Term Results of Primary Stenting for Long and Complex Iliac Artery Occlusions

Roeck, A. De; Hendriks, Jeroen; Delrue, F.; Lauwers, Patrick; Schil, Paul Van; Maeseneer, M. De; François, O.; Parizel, P.M.; d'Archambeau, O

doi:10.1080/00015458.2006.11679868

Cited by 32 publications

(17 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nineteen studies were included in the systematic review. [22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40] Four studies originated from two study groups but considered different patient groups and were not excluded. 25,31,33,37 The chance adjusted inter-reviewer agreement for study eligibility () was 0.76.…”

Section: Resultsmentioning

confidence: 99%

A systematic review of endovascular treatment of extensive aortoiliac occlusive disease

Jongkind

Akkersdijk

Yeung

et al. 2010

Journal of Vascular Surgery

264

163

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

A systematic review of endovascular treatment of extensive aortoiliac occlusive disease

Jongkind

Akkersdijk

Yeung

et al. 2010

Journal of Vascular Surgery

264

163

View full text Add to dashboard Cite

show abstract

“…In the endovascular era, endoluminal treatment has been shown in certain situations to be a comparable option for iliac occlusive disease. [7][8][9][10][11] However, it is not a suitable stand-alone therapy in the presence of significant CFA disease. 12 We have previously reported our initial experience with combined common femoral endarterectomy and EIA stenting as a means to treat TASC C iliac lesions.…”

mentioning

confidence: 98%

Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease

Chang

Goodney

Baek

et al. 2008

Journal of Vascular Surgery

177

110

View full text Add to dashboard Cite

show abstract

“…At follow-up, 15 patients (50%) were asymptomatic, 13 presented long distance claudication (Rutherford category 1) and two presented moderate distance claudication. The mean neointimal hyperplasia volume was 766.26 mm 3 (minimum of 204 mm 3 and maximum of 1774 mm 3 ). The intrastent occlusion rate caused by neointimal hyperplasia ranged from 18% to 47% (mean, 27.4%) (Figure 3).…”

Section: Resultsmentioning

confidence: 99%

Quantificação volumétrica da hiperplasia neointimal em artérias ilíacas após implante de suporte intravascular metálico

et al. 2009

View full text Add to dashboard Cite

OBJECTIVE: To quantify neointimal hyperplasia in iliac arteries after stent implantation, correlating clinical, arterial factors and stent material. MATERIALS AND METHODS: In the period from June/2003 to August/ 2005, 60 patients were submitted to percutaneous transluminal angioplasty and stenting. Among these patients, 30 were followed-up with intravascular ultrasonography. Data were analyzed in a laboratory of quantitative analysis by means of a specific software. RESULTS: Sixteen (53.3%) patients were men, and 14 (46.7%), women, and the mean age was 60.3 years. Arterial hypertension was observed in 22 patients (73.3%), smoking in 18 (62.1%), hyperlipidemia in 20 (66.7%), and diabetes in 9 (30%). A total of 20 nitinol stents (66.7%) and 10 stainless steel stents (33.3%) were implanted. Four patients were classified as TASC A (13.3%), 15 TASC B (50%) and 11 TASC C (36.7% ). The rate of intrastent obstruction ranged from 18% to 47% (mean, 27.4%). The clinical outcomes achieved with stenting were sustained through the follow-up. CONCLUSION: Neointimal hyperplasia is a common finding after percutaneous transluminal angioplasty and stenting, but in the present study the stenosis rate was never higher than 50%. There was no statistically significant difference in intrastent stenosis rates in relation to stents materials, clinical and arterial risk factors. Keywords: Stent; Iliac artery; Interventional ultrasonography; Hyperplasia.OBJETIVO: Quantificar a hiperplasia neointimal em artérias ilíacas após stent, correlacionando fatores clíni-cos, arteriais e materiais dos stents. ). O percentual de obstrução intra-stent variou de 18% a 47% (média de 27,4%). Os resultados clínicos obtidos com stent se mantiveram até o reestudo. CONCLUSÃO: A hiperplasia neointimal sempre ocorre após a angioplastia transluminal percutânea e stent, porém os percentuais de obstrução não foram superiores a 50% em nenhum caso. Não houve diferença estatisticamente significante dos percentuais de obstrução intra-stent quanto aos materiais dos stents, aos fatores clínicos e aos fatores arteriais. Unitermos: Stent; Artéria ilíaca; Ultrassonografia de intervenção; Hiperplasia. Intra-stent restenosis caused by neointimal hyperplasia has its occurrence peak around the sixth postoperative month (Figure 1), and it has been described in other locations such as the coronary arteries although such occurrence has not been reported with the same frequency as in the case of iliac arteries.In the present study, intravascular ultrasonography (IVUS) was performed to quantify the volume of neointimal hyperMoreira SM, Kambara AM, Ajzen S, Costa Junior JR. Volumetric assessment of neointimal hyperplasia in iliac arteries after metal stent implantation. Radiol Bras. 2009;42(4):231-234.

show abstract

Long-Term Results of Primary Stenting for Long and Complex Iliac Artery Occlusions

Cited by 32 publications

References 0 publications

A systematic review of endovascular treatment of extensive aortoiliac occlusive disease

A systematic review of endovascular treatment of extensive aortoiliac occlusive disease

Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease

Quantificação volumétrica da hiperplasia neointimal em artérias ilíacas após implante de suporte intravascular metálico

Contact Info

Product

Resources

About